Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and health foods in Taiwan. It provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia in women before menopause and relieved dysmenorrhea. The company is also involved in the sale of organic food and beverages; provision of technology development, transfer, and consulting services; and publishing of magazine, as well as offers business consulting services. Microbio Co., Ltd. was incorporated in 2000 and is based in Taipei, Taiwan.
Frequently asked questions
What sector does Microbio Co Ltd (4128) operate in?
Microbio Co Ltd belongs to the Consumer Staples sector and operates in the Packaged Foods industry.
What is Microbio Co Ltd (4128) current stock price?
As of the latest data, Microbio Co Ltd stock price is NT$15.00, with a previous close of NT$15.00.
What is Microbio Co Ltd (4128) current market capitalization?
Microbio Co Ltd market cap is approximately 8.82 billion.
What is Microbio Co Ltd (4128) Earnings Per Share (EPS)?
The trailing EPS is -NT$1.18.
Does Microbio Co Ltd (4128) pay dividends?
No. Microbio Co Ltd does not pay a dividend.
What is Microbio Co Ltd (4128) beta (volatility) score?
Microbio Co Ltd has a beta of 0.450, indicating lower volatility than the overall market.
